We also found that RHOJ—a small GTPase of the Cdc42 subfamily that was previously described to mediate resistance to therapy in melanoma13,14—was expressed at a much higher level in EMT tumour cells (Fig. 2a and Extended Data Fig. 2a). Here, RHOJ is linked to neoplasm.